Tirzepatide reduced the risk of developing type 2 diabetes by 94% and resulted in sustained weight loss over the three-year treatment period
Together, these changes position menopause as a critical inflection point in the trajectory of metabolic health
Coverage for medical weight loss treatments varies depending on your insurance plan and specific medical conditions
As peptide therapy is based on natural body function, it is very safe
After the Gold Rush: What Comes Next for GLP-1s Inside the post-compounding GLP-1 market: pharmas pivot, DTCs ceiling, and payer infrastructure at scale
Yes, GHK/Epithalon integrates well with comprehensive longevity and aesthetic protocols including other peptides, hormone optimization, NAD+ therapy, senolytics, cosmetic procedures, and lifestyle interventions